Qube Research & Technologies LTD Aravive, Inc. Transaction History

Qube Research & Technologies LTD

  • $61.9 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$0.11 - $0.22 $51 - $102
-465 Reduced 46.22%
541 $0
Q3 2023

Nov 13, 2023
BUY
$0.11 - $1.76 $110 - $1,770
1,006 New
1,006 $0
Q1 2023

May 15, 2023
BUY
$1.29 - $2.46 $69,555 - $132,640
53,919 New
53,919 $107,000

Others Institutions Holding ARAV

# of Institutions
4
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Aravive, Inc.

ARAV Quotes by TradingView
  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email